TaVNS Reduces Postoperative Pain and Complications in Patients with Gastric and Intestinal Tumors

Launched by SECOND AFFILIATED HOSPITAL, SCHOOL OF MEDICINE, ZHEJIANG UNIVERSITY · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring the use of a treatment called transcutaneous auricular vagus nerve stimulation (TaVNS) to help reduce pain and complications after surgery for patients with gastric and intestinal tumors. Many patients experience significant pain and other issues after these surgeries, which can slow down recovery and lead to longer hospital stays. The goal of this study is to see if TaVNS can improve recovery by reducing pain, improving gut function, and minimizing other complications related to surgery.

To participate in this trial, you need to be between 18 and 80 years old and have a body mass index (BMI) between 18 and 30. You should be scheduled for elective laparoscopic surgery on your stomach or intestines that is expected to last at least two hours. It's important that you understand the study and agree to participate by signing a consent form. However, if you have certain health conditions like kidney problems, severe heart issues, or dementia, you may not be eligible to join. If you do participate, you can expect to receive the TaVNS treatment during your surgery, which could help with your recovery process.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 18-80 years, BMI 18-30 kg/m², ASA Ⅱ-Ⅲ, elective laparoscopic gastric or intestinal tumor surgery, expected surgical duration ≥2 hours, patient understands study content and signs informed consent form.
• Exclusion Criteria:
• • Kidney replacement therapy, treatment for arrhythmias requiring treatment, dementia, severe bradycardia, orthostatic tachycardia syndrome, neuro-muscular disorders, auricular dermatitis, planned post-operative transfer to ICU